Skip to main content
Log in

Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro

  • ORIGINAL PAPER
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

The effect of doxycycline, obtained from human volunteers administered doxycycline, on the minimum inhibitory concentration (MIC) of atovaquone was determined against the K1 and FC27 isolates of Plasmodium falciparum in vitro. Doxycycline concentrations ranging from 0.10-1.18 μg/ml added to atovaquone produced MIC ratios [atovaquone + doxycycline/atovaquone alone] ranging from 0.38 to 0.70. These results suggest that the antimalarial activity of atovaquone is potentiated by doxycycline. Additionally, these drugs may be rational partners for the treatment and prophylaxis of falciparum malaria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 4 October 1996 / Accepted: 29 November 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yeo, A., Edstein, M., Shanks, G. et al. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res 83, 489–491 (1997). https://doi.org/10.1007/s004360050285

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004360050285

Keywords

Navigation